로딩 중…
지수 로딩 중…
BioCryst Pharmaceuticals, Inc.
BCRX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$8.99+0.45%
2026-06-18
Price Chart
BioCryst Pharmaceuticals, Inc.-9.74%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $2.28B |
| Revenue | $886M |
| Net Income | $-458M |
| Total Assets | $465M |
| Net Assets | $-554M |
| Value | |
| P/S | 2.58x |
| FCF Yield | 12.85% |
| Profitability | |
| ROA | -98.48% |
| Op. Margin | -43.11% |
| Revenue Growth | 7.48% |
| Earnings Growth | -2255762.50% |
| Financial Health | |
| Total Debt | $858M |
| FCF | $294M |
| Cash | $172M |
| Current Ratio | 1.91x |
| Performance | |
| 1Y Return | -9.74% |
| 1M Return | 2.51% |
| From 52W High | -12.89% |
| 1Y MDD | -44.24% |
| Trading | |
| Volume | 7,295,553 shares |
| Trading Value | $67M |
| Per Share | |
| EPS | $1.25 |